CellaVision AB (publ) (STO:CEVI)
Sweden
· Delayed Price · Currency is SEK 186.00
-1.20 (-0.64%)
Feb 21, 2025, 5:29 PM CET
CellaVision AB Revenue
In the year 2024, CellaVision AB had annual revenue of 723.22M SEK with 6.78% growth. CellaVision AB had revenue of 186.69M in the quarter ending December 31, 2024, a decrease of -6.95%.
Revenue
723.22M
Revenue Growth
+6.78%
P/S Ratio
6.13
Revenue / Employee
3.17M
Employees
228
Market Cap
4.44B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 723.22M | 45.93M | 6.78% |
| Dec 31, 2023 | 677.29M | 37.95M | 5.94% |
| Dec 31, 2022 | 639.34M | 73.79M | 13.05% |
| Dec 31, 2021 | 565.55M | 94.11M | 19.96% |
| Dec 31, 2020 | 471.44M | 9.67M | 2.09% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.03B |
| Getinge AB | 34.76B |
| Sectra AB | 3.14B |
| Camurus AB | 1.87B |
| Medicover AB | 23.97B |
| Vitrolife AB | 3.61B |
| Elekta AB | 17.88B |
| Vimian Group AB | 4.29B |
CellaVision AB News
- 14 days ago - CellaVision AB (CLVSF) Q4 2024 Earnings Call Highlights: Record APAC Sales and Strategic Growth ... - GuruFocus
- 14 days ago - Q4 2024 CellaVision AB Earnings Call Transcript - GuruFocus
- 4 months ago - Q3 2024 CellaVision AB Earnings Call Transcript - GuruFocus
- 4 years ago - 3 Scandinavian Companies With Strong Margin Growth - GuruFocus